Last update 01 Nov 2024

Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)

1935

Overview

Related

14
Drugs associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
Polihexanide
Target-
Mechanism-
Active Org.
SIFI SpASIFI SpA [+1]
Originator Org.
B. Braun Medical, Inc.B. Braun Medical, Inc.
Active Indication
Acanthamoeba Keratitis [+2]
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
EU [+3]
First Approval Date22 Aug 2024
Dexamethasone/Netilmicin Sulfate
Target
30S subunit x GR
Mechanism
30S subunit inhibitors [+1]
Active Org.
SIFI SpASIFI SpA [+1]
Originator Org.
Knight Therapeutics, Inc.Knight Therapeutics, Inc.
Active Indication
Bacterial Infections [+1]
Inactive Indication
Cataract [+1]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
LB
First Approval Date22 Jul 2016
GL-101
Target-
Mechanism-
Active Org.-
Originator Org.
Gliacure, Inc.Gliacure, Inc.
Active Indication-
Inactive Indication
Corneal Diseases [+4]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
Login to view more data
0 Patents (Medical) associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
Login to view more data
100 Deals associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
Login to view more data
100 Translational Medicine associated with Societá Industria Farmaceutica Italiana Spa (S.I.F.I.)
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 17 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
14
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
SF-103
Glaucoma
More
Pending
SF-111
Inflammation
More
Pending
SF-106
Retinal Diseases
More
Pending
SF-116
Glaucoma
More
Pending
Polihexanide
Acanthamoeba Keratitis
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free